High-throughput mass spectrometry as a drug discovery tool was a highlight of SLAS 2017 as it has been over the last few years. In 2013 and 2015 the SLAS Innovation Award for best presentation of the conference went to high-throughput mass spectrometry projects. This year saw important advances in HT-MALDI-MS as Bruker Daltonics continues to make instrumentation improvements to it's MALDI PharmaPulse instrument platform and recognized as the SelectScience Scientist's Choice Awardee for "Best New Drug Discovery & Development Product of 2016". At the same time AMRI announced that they had entered an alliance with Bruker Daltonics and HighRes Biosolutions in implementing HT-MALDI-MS for drug discovery. link
These developments, along with the past awards, demonstrate the appeal, importance, and potential impact of HT-MS in drug discovery. MS2 Array's technology is fully compatible with all MALDI-MS instruments and provides vital enhancements to HT-MALDI-MS such as analyte enrichment, greater sensitivity, full assay design freedom, and complete bio-orthgonality.